
Exhibit 99.2 Amdocs Limited NASDAQ: DOX Fiscal Q3 2026 Earnings
Presentation August 5, 2026 Shimie Hortig President & CEO Tal Rozenfeld Chief Financial Officer 1 Information Security Level 2 – Sensitive. © 2026 – Proprietary & Confidential Information of Amdocs

Forward-Looking Statement The information contained herein in this
presentation or delivered or to be delivered to you during this presentation does not constitute an offer, expressed or implied, or a recommendation to do any transaction in Amdocs Limited securities or in any securities of its affiliates or
subsidiaries. This presentation and the comments made by members of Amdocs management in conjunction with it can be found on the Investor Relations section of our website, and, as always, a copy of today’s prepared remarks will also be posted
immediately following the conclusion of this call. This presentation includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including
statements about Amdocs’ strategy, including with respect to artificial intelligence and agentic opportunities, growth, financial outlook and business results in future quarters and years. Although we believe the expectations reflected in such
forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks, uncertainties and other important factors
that may cause future results to differ materially from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty,
including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the
Company’s customers’ businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company’s customers, Amdocs’ ability to grow in
the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, security
incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and
effectively implement artificial intelligence and Generative AI in the Company’s offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements
at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report
on Form 20-F for the fiscal year ended September 30, 2025 filed on December 15, 2025, and for the first quarter of fiscal 2026 on February 17, 2026, and for the second quarter of fiscal 2026 on May 26. 2026. This presentation includes non-GAAP
financial measures, including non-GAAP operating margin, free cash flow, revenue on a constant currency basis, non-GAAP net income, non- GAAP net income attributable to Amdocs Limited, and non-GAAP earnings per share. Free cash flow equals cash
generated by operating activities less net capital expenditures. While in prior years Amdocs used normalized free cash flow, Amdocs is no longer reporting normalized free cash flow. Normalized free cash flow is not comparable to free cash flow.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial
measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations
as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures. Please refer to the appendix for a reconciliation of these metrics
to the most comparable GAAP provision. Amdocs believes that these measures provide useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the
net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business. This presentation also includes pro forma metrics which exclude the financial impact of OpenMarket
(divested on December 31, 2020) from fiscal year 2021. Please also review the information contained in Amdocs’ press release dated August 5, 2026, with respect to earnings for fiscal Q3 2026. The press release contains additional information
regarding Amdocs’ outlook for fiscal year 2026 and certain non-GAAP metrics and their reconciliations. 2 2 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026
2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Today’s speakers President & Chief Executive Officer Chief
Financial Officer 3 Information Security Level 2 – Sensitive. © 2026 – Proprietary & Confidential Information of Amdocs

Agenda Strategy & Business Performance Update Shimie Hortig
President & Chief Executive Officer Financial Review & Outlook Tal Rozenfeld Chief Financial Officer Q&A 4 4 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. ©
© 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

President & Chief Executive Officer Strategy and Business
Performance Update 5 Information Security Level 2 – Sensitive. © 2026 – Proprietary & Confidential Information of Amdocs

1 Business Performance Update 6 6 IIn nf fo or rm ma at tiio on n S Sec
ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs
s

Q3 Financial Highlights Revenue Non-GAAP Non-GAAP 12-Month (1) (1)
operating margin EPS Backlog $1.175B 21.6% $1.84 $4.26B At guidance Up 20bps At guidance Up 2.7% midpoint YoY midpoint YoY Managed services delivered a record quarter, accounting for 67% of total revenue 1. Non-GAAP. See reconciliation tables in
appendix 7 7 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In
nffor orm ma at tiion on of of A Am md doc ocs s

FY2026 Outlook (1) (2) Revenue Non-GAAP EBIT 2.6% - 3.4% 21.3% - 21.9%
YoY growth % margin • Reiterate 21.6% midpoint • Reiterate 3.0% midpoint in constant (1) currency • Up 20bps YoY (3) (2) Free cash flow Non-GAAP EPS $710m - $730m 5.5% - 6.5% YoY growth • Reiterate $720m midpoint •
Reiterate 6.0% midpoint • ~90% earning-to-cash conversion 1. Constant currency. Assumes exchange rates in the current period were unchanged from the prior period 3. Excludes restructuring related payments 2. Non-GAAP. See reconciliation tables
in appendix 8 8 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In
nffor orm ma at tiion on of of A Am md doc ocs s

Key Customer Wins New, large scale multi-year partnership with Liberty
Latin America Manage and transform its entire end-to-end IT ecosystem Major proof-point of the Agentic transformation strategy US digital TV Scandinavia entertainment provider Service orchestration Core Platform Billing aOS driven Customer
Engagement ConnectX OSS modernization Modernization Migration customer engagement Transformation SaaS Platform Modernization 9 9 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve..
© © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Q3 Project Execution & Delivery Key milestones Austria Billing
Modernization Charging US Cellular Go-Live migration integration Enterprise Charging 5G policy catalog deployment data migration modernization Digital Commerce Execution of charging Bill Presentment Rollout transition services go live 10 10 IIn nf
fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion
on of of A Am md doc ocs s

2 The Amdocs Strategy 11 11 IIn nf fo or rm ma at tiio on n S Sec ecu
ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs
s

Amdocs Strategy 1 2 3 Agentic Telco New Vertical Emerging Growth
Operating System Expansion Horizons (aOS) Transforming our customers to Accelerate Agentic modernization in Capture & solve emerging needs the Agentic era additional industry driven by the GenAI revolution Internal Transformation 4 Become an
Agentic-first organization as a key enabler to support our future growth 12 12 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop
oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Agentic Governance 1 Amdocs Agentic Telco Operating System Our mission
is to accelerate the transformation of each of our customers to the Agentic era Agentic IT Ops. This transformation will allow 1 our customers to: Agentic Business Workflows Agentic Telco ü Simplify complexity Operating System ü Re-imagine
end-to-end workflows (aOS) Agentic Core Transforming our customers to the ü Accelerate the launch of new offerings BSS/OSS Agentic era from months to hours Agentic Delivery ü Significantly reduce their cost structures 13 13 IIn nf fo or rm
ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of
A Am md doc ocs s Agentic Orchestration

1 Strategic Win: Liberty Latin America Strategic Engagement to
Transform and Manage its Entire IT Domain Through Amdocs aOS 10-year strategic engagement to transform and manage its end-to-end IT ecosystem AI driven operations Demonstrates ability to handle highly complex operations across multiple markets
Meaningful expansion of Amdocs’ footprint in the CALA region Business value Accelerate Service & product Improve customer & deliver significant time to market innovation employee experience cost savings 14 14 IIn nf fo or rm ma at tiio
on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc
ocs s

1 aOS Market Traction Customer Engagements In Production Q3 New Deals
Customer care Agentic network engineering Marketing Sales Switzerland Operations Scandinavia Billing care Sales Sales digital twin Tier 1 Asia Pacific Billing Customer care Operator 15 15 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev
evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

2 New Vertical Expansion Expand our addressable market by targeting
additional vertical Enter an additional market 2 with our disruptive Agentic approach New Vertical ü Track record of successfully executing major core system Expansion transformations Accelerate Agentic ü Unique Agentic offering
modernization in additional industry ü Especially relevant in other high volume, mission critical and strictly regulated industries 16 16 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit
tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

3 Emerging Growth Horizons The GenAI revolution is creating demand to
solve technological gaps and needs that didn’t exist before Future new growth drivers for Amdocs 3 Emerging Growth ü Be the first to market with disruptive technologies Horizons ü Leverage Agentic skill-set and deep industry
knowledge Capture & solve emerging needs driven by GenAI ü Incubate and scale the ones with the greatest potential 17 17 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve..
© © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

4 Internal Transformation Agentic-first company with the right
foundation to support our future growth Reshaping the organization: 4 ü Become “Customer Zero” Internal ü Implementing Agentic capabilities across: Transformation ü Software development ü Service delivery Become an
Agentic organization as a key enabler to support our ü Operations future growth 18 18 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P
Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Bringing it all together 1 2 We have the right strategy to seize this
Our recent commercial momentum exciting opportunity for Amdocs is an important proof point and our telco customers 4 3 We see opportunities to expand We’ve got the right talent, skills and beyond telco to an additional leadership necessary to
quickly vertical and new emerging horizons adapt and drive us forward 19 19 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie
et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Chief Financial Officer Financial Review & Outlook 20 Information
Security Level 2 – Sensitive. © 2026 – Proprietary & Confidential Information of Amdocs

Q3 FY2026 Financial Results Key Metrics: (2) (2) Non-GAAP GAAP Non-GAAP
Revenue Operating Margin Diluted EPS Diluted EPS $1,175m 21.6% $0.59, incl. $0.91 $1.84, in line with +20 bps YoY, restructuring charges. guidance midpoint of +2.7% YoY as reported $1.81 – $1.87 (1) +10 bps QoQ Ex- restructuring, GAAP +2.2%
YoY constant currency diluted EPS was above guidance ($1.39 - $1.47) Q3 2026 Revenue vs. Guidance $ Millions $1,175 $1,175 Revenue in line with the (2) Free cash flow of $193M guidance midpoint, including before restructuring a negligible impact
from foreign currency movements payments in Q3 compared to guidance Original Q3F26 Q3F26A Guidance (midpoint) 1. Constant currency. Assumes exchange rates in the current period were unchanged from the prior period 2. Non-GAAP. See reconciliation
tables in appendix 21 21 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia
all I In nffor orm ma at tiion on of of A Am md doc ocs s

Managed Services Supporting visibility and business resilience Record
Managed Services revenue Close to managed services contract renewals ~100% ~67% of Q3 FY2026 Managed services arrangements support revenue business model resiliency with highly recurring revenue streams, multi-year engagements and Q3F25 Q3F26 high
renewal rates, and may also include large- scale digital transformation projects South Multi-year agreement, Extended managed New Strategic biller migration US digital TV American leveraging Amdocs' full services agreement for program, leveraging
entertainment service BSS/OSS stack with AI-driven Amdocs CES operations Amdocs’ AI-driven migration provider provider support capabilities 22 22 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en
ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

(1) Q3 2026 Free cash flow bridge Balance Sheet & FCF before
restructuring payments of $21M was $193M in Q3 Cash Flow $193 $197 $25 * $172 Cash + Available Credit Facility Cash, Credit Facility & Debt Position $726 million $ Millions, as of June 30, 2026 Ample liquidity to support $280 ongoing business
needs while (2) * retaining the capacity to fund Operating Cash Net capex Reported FCF Available future strategic growth $520 Flow (2) credit facility as of 6/30 (3) $650 Baa1 BBB DSO’s Moody’s S&P 78 days Cash $206 +2 days YoY and
+5 days QoQ Committed to maintaining our DSO’s may fluctuate from quarter to quarter Investment grade credit rating Liquidity Debt Unbilled receivables net of deferred revenue increased by $98 million compared to a year ago and by $68 million
sequentially in Q3, aggregating the short-term and long-term 1. Non-GAAP. See reconciliation tables in appendix balances 2. Short-term financing arrangements as of June 30, 2026: $80M drawn on $800M revolving credit facility and $200M outstanding
notes through U.S. Commercial Paper leaving available capacity of $520M The net difference between unbilled receivables and deferred revenue 3. $650M senior note, maturing June 2030 fluctuates from quarter to quarter, in line with normal business
activities as well as progress on multi-year transformation programs 23 23 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et
ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Dividends $60 Disciplined Capital Allocation FCF: Six-year historical
trend and FY2026E outlook Share repurchases 140% $143 (1)(2)(3)(4)(5) 102% % FCF / 101% $203M 94% 93% 90% 88% Non-GAAP Net Returned to shareholders in Q3 (1) Income FY2026E 112% 106% 104% 100% 99% (1)(2)(3)(4)(5) 96% guidance: % of FCF return
Returned to majority Dividend Shareholders Board authorized quarterly dividend payment: (1)(2)(3)(4)(5) FCF ($M) $869 $735 $720 $718 $694 $665 $527 56.9 cents Payable October 30, 2026 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026E (Guidance)
(1)(2) Normalized Share Repurchase Authorization (1) ~$0.6B aggregate remaining share FY 2026 free cash flow target ~90% repurchase authorization reiterated: $710-$730M Earnings to cash conversion (before restructuring payments) 3. Refer to
https://investors.amdocs.com/ and earnings reports issued on 11/2/2021 and 11/8/2022 for reconciliation of normalized FCF in FY2020, FY2021 and FY2022 1. Non-GAAP. See appendix tables for reconciliation of FCF 4. FY2023, FY2024, and FY2025, exclude
restructuring payments of ~$20M,~$75M.~$90M, 2. FCF in FY2020, FY2021 and FY2022 is presented on a normalized basis, which mainly excludes net capital expenditures respectively related to the new campus development; normalized FCF disclosure is not
applicable as of FY2023 onward 5. FY2026 assumes midpoint of $710-$730M guidance range, before restructuring payments 24 24 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. ©
© 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Leading Indicators & Visibility: 12-month Backlog Up 2.7% YoY
12-Month Backlog 12-month backlog includes: Down $20M QoQ Anticipated revenue related to contracts $4.26B Estimated revenue from managed services contracts Letters of intent Quarterly 12-Month Backlog Growth YoY % Maintenance 3.2% 3.0% Estimated
ongoing support activities 2.7% 2.6% 2.7% 1. For comparison purposes, pro forma adjusts quarterly revenue from Q124 to Q4F24 by approximately $150 million, and fiscal 2024 revenue by approximately $600 million, to reflect the end of certain low
margin, non- core business activities; these activities substantially already ceased in the first quarter fiscal 2025 and were not included in the full year fiscal 2025 Q3F25 Q4F25 Q1F26 Q2F26 Q3F26 revenue outlook (1) (1) 25 25 IIn nf fo or rm ma
at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siiti tiv ve e.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A
Am md doc ocs s

FY2026 Revenue Growth Outlook FY2026 revenue growth: Revenue Growth (3)
YoY% Growth Constant Currency Outlook tightened to 2.6%-3.4% YoY (3) constant currency 10.3% 7.7% • Expects 3.2%-4.0% as reported, including a 7.0% foreign currency benefit of 60 bps, unchanged as compared with prior quarter Reiterating 3.1%
3.4% assumption 2.7% 2.4% 3.0% 3% guidance 2.6% midpoint • Roughly half of the expected growth in fiscal 2026 expected to be inorganic in nature FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026E (3) (2)(3) (2)(3) (3) (3) (1)(3) (3) 1. For
comparison purposes, pro forma fiscal 2024 revenue by approximately $600 million to reflect the end of certain low margin, non-core business activities; these activities substantially already ceased in the first quarter fiscal 2025 and are not
included in the full year fiscal 2025 revenue outlook 2. Pro forma metrics exclude the financial impact of OpenMarket (which was divested on December 31, 2020) from fiscal year 2021. 3. Constant currency. Assumes exchange rates in the current period
were unchanged from the prior period 26 26 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con
onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Sustained Margin Expansion in FY2026 Balancing growth investments with
accelerated internal transformation to become an agentic-first organization (1) Annual Non-GAAP Operating Margin: (2) FY2020 – FY2026E +20 bps YoY at the midpoint of the FY2026 target range of FY2026E: +20 bps YoY 21.3%-21.9% 21.6% 21.9% 21.4%
21.7% 21.3%-21.9% Balancing generative AI 21.3% growth investments with 21.1% FY2025 +300 bps YoY: internal transformation and Business activity phase out & implementation of agentic internal efficiency gains capabilities to reshape cost and
drive efficiency 18.4% 18.7% 17.8% Operating margin may 18.1% 17.6% 17.5% 17.8% fluctuate slightly between 17.2% 17.5% quarters 17.2% 16.5% 1. Non-GAAP. See reconciliation tables in appendix 2. Refer to https://investors.amdocs.com/ and earnings
Guidance Range Non-GAAP Operating Margin reports issued on 11/10/20, 11/2/2021, 11/8/2022, 11/7/2023, 11/12/2024 and 11/11/2025 for reconciliation of non-GAAP operating margin in FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024 and FY2025 27
27 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siiti tiv ve e.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm
ma at tiion on of of A Am md doc ocs s

FY2026 Non-GAAP Diluted EPS Growth Outlook Reiterating the 6% midpoint
(3)(4) Total Shareholder Return 14.1% (2) Non-GAAP Diluted EPS Growth YoY % + Dividend Yield 13.6% 11.7% 11.2% (2) 11.1% Non-GAAP EPS growth outlook 12.1% tightened to 5.5%-6.5% in FY2026E 11.5% 8.7%* 9.8% 9.0% Reiterating 8.5% Reiterating 6%
midpoint guidance 6.5% 5.3% 6.0% 6.0% guidance 5.5% midpoint 3.0% 2.7% 2.3% 2.2% 2.6% 2.1% 2.0% 1.9% (1) (1) FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026E 1. Pro forma metrics exclude the financial impact of OpenMarket (which was divested on
December 31, 2020) from fiscal year 2021. 2. Non-GAAP. See reconciliation tables in appendix Non-GAAP Diluted EPS Growth Dividend Yield Total Shareholder Return 3. Expected total shareholder return assumes Non-GAAP EPS growth plus dividend yield
(based on fiscal year end closing share price); FY2026E assumed 6.0% (2) (3) midpoint of non-GAAP EPS outlook, and dividend yield based on quarterly rate of *Non-GAAP EPS growth of 6.0%, plus 2.7% dividend yield $0.569 as of share price on 11/11/25
4. Refer to https://investors.amdocs.com/ and earnings reports issued on 11/10/2020, 11/2/2021, 11/8/2022, 11/7/2023, 11/12/2024 and 11/11/2025 for non- GAAP reconciliation in FY2020, FY2021, FY2022, FY2023, FY2024 and FY2025 28 28 IIn nf fo or rm
ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siiti tiv ve e.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of
A Am md doc ocs s

Q&A 29 29 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L
Lev evel el 2 2 – – S Se en ns siiti tiv ve e.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Q4 Fiscal 2026 Outlook Revenue $1,175 - $1,215 million GAAP EPS $1.48 -
$1.56 Q4 & (1) Non-GAAP EPS $1.94 - $2.00 Share Count 106 million FY2026 Non-GAAP effective tax rate within the annual Tax guidance range of 16.0%-19.0% Outlook FY 2026 Outlook Updated Previous Revenue growth 3.2% - 4.0% 2.6% - 4.6% As reported
Revenue growth 2.6% - 3.4% 2.0% - 4.0% (2) Constant currency GAAP EPS Growth (5.0)% - (3.0)% 12.0% - 15.0% 1. Non-GAAP. See reconciliation tables in appendix. Free cash (1) Non-GAAP EPS growth 5.5% - 6.5% 5.0% - 7.0% flow outlook is before expected
restructuring payments 2. Constant currency. Assumes exchange rates in the current Operating Margin period were unchanged from the prior period 21.3% - 21.9% 21.3% - 21.9% (1) Non-GAAP Effective Tax Rate 16.0% - 19.0% 16.0% - 19.0% (1) Non-GAAP Free
Cash Flow $710-$730 million $710-$730 million 30 30 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & &
C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Appendix Outlook & Reconciliation Tables 31 31 IIn nf fo or rm ma
at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A
Am md doc ocs s

Reconciliation Tables a) The amounts under Purchase of property and
equipment, net”, include immaterial proceeds from sale of property and equipment for the three and nine months ended June 30, 2026 and 2025, respectively. 32 32 IIn nf fo or rm ma at tiio on n S Sec ecu ur riit ty y L Lev evel el 2 2 –
– S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs s

Reconciliation Tables 33 33 IIn nf fo or rm ma at tiio on n S Sec ecu
ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs
s

Reconciliation Tables 34 34 IIn nf fo or rm ma at tiio on n S Sec ecu
ur riit ty y L Lev evel el 2 2 – – S Se en ns siit tiive ve.. © © 2026 2026 – – P Prrop oprriie et ta arry y & & C Con onffiid de en nt tiia all I In nffor orm ma at tiion on of of A Am md doc ocs
s

35 Information Security Level 2 – Sensitive. © 2026 –
Proprietary & Confidential Information of Amdocs